Quick Answer
BioScience Health Innovations, Inc. reported Total Revenue of $5.69 million for fiscal year 2025.
BioScience Health Innovations, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.69M +208.3% |
$1.84M +208.7% |
$597.6K | $0.00 | $0.00 | $0.00 |
| Net Income | $642.1K +638.0% |
$87.0K +134.6% |
-$251.5K -202.3% |
-$83.2K -224.9% |
-$25.6K -233.4% |
-$7.7K |
| Diluted EPS | $0.06 +500.0% |
$0.01 +200.0% |
-$0.01 | — | — | — |
| Total Assets | $1.71M +95.4% |
$873.8K +835.7% |
$93.4K +474.6% |
$16.3K +157.4% |
$6.3K -69.4% |
$20.6K +985.7% |
| Cash and Equivalents | $661.9K -0.1% |
$662.5K +3343.8% |
$19.2K +66.3% |
$11.6K +468.5% |
$2.0K -90.1% |
$20.6K |
| Stockholders Equity | $1.48M +76.9% |
$835.2K +12455.6% |
-$6.8K -147.0% |
$14.4K +212.5% |
-$12.8K -199.8% |
$12.8K |
| Operating Income | $719.1K +726.5% |
$87.0K +134.6% |
-$251.5K -173.6% |
-$91.9K -258.9% |
-$25.6K -233.4% |
-$7.7K |
| Gross Profit | $3.24M +147.6% |
$1.31M +170.2% |
$484.4K +712.2% |
$59.6K | — | — |
| Shares Outstanding | 10.98M +0.0% |
10.98M -73.2% |
40.90M +648.8% |
5.46M +0.0% |
5.46M +0.0% |
5.46M +95.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.13M | +97.5% | -35.6% |
| Net Income | September 30, 2025 | -$8.8K | -115.6% | -101.9% |
| Diluted EPS | September 30, 2025 | $0.00 | -100.0% | -100.0% |
| Total Assets | September 30, 2025 | $2.07M | +397.1% | +0.5% |
| Cash and Equivalents | September 30, 2025 | $1.14M | +241.9% | -12.3% |
| Stockholders Equity | September 30, 2025 | $1.71M | +362.1% | -0.5% |
| Operating Income | September 30, 2025 | -$8.8K | -115.6% | -101.9% |
| Gross Profit | September 30, 2025 | $698.2K | +64.4% | -35.0% |
| Shares Outstanding | September 30, 2025 | 10.98M | -73.9% | -75.0% |
- BioScience Health Innovations, Inc. reported Total Revenue of $5.69 million for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +208.3% in Total Revenue compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Net Income of $642.1 thousand for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +638.0% in Net Income compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Diluted EPS of $0.06 per share for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +500.0% in Diluted EPS compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Total Assets of $1.71 million for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +95.4% in Total Assets compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Cash and Equivalents of $661.9 thousand for fiscal year 2025.
- BioScience Health Innovations, Inc. showed a decrease of -0.1% in Cash and Equivalents compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Stockholders Equity of $1.48 million for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +76.9% in Stockholders Equity compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Operating Income of $719.1 thousand for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +726.5% in Operating Income compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Gross Profit of $3.24 million for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +147.6% in Gross Profit compared to the prior fiscal year.
- BioScience Health Innovations, Inc. reported Shares Outstanding of 10.98 million shares for fiscal year 2025.
- BioScience Health Innovations, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: